Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
17.28
-0.72 (-4.00%)
At close: Jun 8, 2026, 4:00 PM EDT
17.28
0.00 (0.00%)
After-hours: Jun 8, 2026, 4:10 PM EDT
Crescent Biopharma Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Crescent Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $31.67. The average 1-year stock price forecast is 83.28% higher than the current stock price, while the lowest is $27 (+56.25%) and the highest is $35 (+102.55%).
Price Target: $31.67 (+83.28%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Crescent Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 1, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $35 | Buy | Maintains | $35 | +102.55% | May 26, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $30 | Buy | Maintains | $30 | +73.61% | May 1, 2026 |
| Wedbush | Wedbush | Buy Reiterates $27 | Buy | Reiterates | $27 | +56.25% | Apr 30, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $35 | Buy | Maintains | $35 | +102.55% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
2.08M
from 10.84M
Decreased by -80.80%
Revenue Next Year
4.93M
from 2.08M
Increased by 136.66%
EPS This Year
-2.62
from -12.81
EPS Next Year
-2.94
from -2.62
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.5M | ||
| Avg | 2.1M | ||
| Low | 1,000,000 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -21.6% | ||
| Avg | -80.8% | ||
| Low | -90.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -2.62 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |